Clinical trial · Interventional
Ask Questions About Clinical Trials
Ask Questions About Clinical Trials (ASQ - CT): An Implementation Trial of a Communication Intervention to Improve Patient-Provider Communication About Clinical Trials and Provider Invitations to Clinical Trials
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall goal of this study is to assess the implementation of the Ask Questions about Clinical Trials (ASQ-CT) brochure, a patient-focused communication tool previously demonstrated to improve patient-provider communication about clinical trials. Participants will be given the ASQ-CT brochure at Time 1 (baseline) and participants will complete a questionnaire at three timepoints, baseline (Time 1), Pre-Research Visit (Time 2), and Post-Research Visit (Time 3).
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cardiac Disease | — | UNRESOLVED | — |
| Neurologic Disorder | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ask Questions about Clinical Trials brochure | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Ask Questions about Clinical Trials (ASQ-CT) Brochure
- description
- Ask Questions about Clinical Trials (ASQ-CT), a clinical trial communication intervention brochure
- interventionNames
- Behavioral: Ask Questions about Clinical Trials brochure
Primary outcomes (1)
- measure
- Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale
- timeFrame
- From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2)
- description
- Improvement of self-efficacy in managing patient-providers interactions between baseline (Time 1) and pre-clinic visit (Time 2). Measured using scale of 1-5 where a higher score is equal to a better outcome
Secondary outcomes (10)
- measure
- Reach - Number and Proportion
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age \> or equal to 18 years * Appointment to see a provider at a Karmanos Cancer Institute-McLaren or a medical encounter at McLaren Center for Research and Innovation (MCRI) site for medical/systemic treatment * Potentially eligible for a clinical trial * Speak and read English well enough to be able to understand consent documents and complete surveys Exclusion Criteria: * Not able to complete study documents on their own physically or cognitively
References
Publications (0)
Data not yet available